| scholarly article | Q13442814 |
| P50 | author | Ingo Schmitz | Q30505584 |
| Marcus E. Peter | Q47824922 | ||
| Stanley J. Korsmeyer | Q138795 | ||
| P2093 | author name string | P H Krammer | |
| C Scaffidi | |||
| J Zha | |||
| P433 | issue | 32 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | apoptotic process | Q14599311 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 22532-22538 | |
| P577 | publication date | 1999-08-01 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Differential modulation of apoptosis sensitivity in CD95 type I and type II cells | |
| P478 | volume | 274 |
| Q37689805 | A Potential of sFasL in Preventing Gland Injury in Sjogren's Syndrome |
| Q36525307 | A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation |
| Q24306159 | A death receptor-associated anti-apoptotic protein, BRE, inhibits mitochondrial apoptotic pathway |
| Q34582647 | A reversible component of mitochondrial respiratory dysfunction in apoptosis can be rescued by exogenous cytochrome c. |
| Q28137979 | A1 functions at the mitochondria to delay endothelial apoptosis in response to tumor necrosis factor |
| Q36670896 | AXL mediates TRAIL resistance in esophageal adenocarcinoma |
| Q28366005 | Accelerating the induction of Fas-mediated T cell apoptosis: a strategy for transplant tolerance? |
| Q34781244 | Acellular fraction of ovarian cancer ascites induce apoptosis by activating JNK and inducing BRCA1, Fas and FasL expression in ovarian cancer cells |
| Q40811155 | Activation of protein kinase C inhibits TRAIL-induced caspases activation, mitochondrial events and apoptosis in a human leukemic T cell line |
| Q34282369 | Activation-induced cell death |
| Q40388128 | Agonists of an ecdysone-inducible mammalian expression system inhibit Fas Ligand- and TRAIL-induced apoptosis in the human colon carcinoma cell line RKO. |
| Q33534861 | Akt activity protects rheumatoid synovial fibroblasts from Fas-induced apoptosis by inhibition of Bid cleavage |
| Q39544012 | Aminopeptidase-N/CD13 is a potential proapoptotic target in human myeloid tumor cells |
| Q33925187 | Amplification of Fas-mediated apoptosis in type II cells via microdomain recruitment |
| Q40161643 | Analysis of CD95 threshold signaling: triggering of CD95 (FAS/APO-1) at low concentrations primarily results in survival signaling |
| Q40775835 | Analysis of FasL and TRAIL induced apoptosis pathways in glioma cells. |
| Q38290909 | Anisomycin activates JNK and sensitises DU 145 prostate carcinoma cells to Fas mediated apoptosis. |
| Q73288772 | Antiapoptotic effect of EGF on mouse hepatocytes associated with downregulation of proapoptotic Bid protein |
| Q90241548 | Antibodies and Derivatives Targeting DR4 and DR5 for Cancer Therapy |
| Q34242758 | Apoptosis and liver diseases: recent concepts of mechanism and significance |
| Q36432437 | Apoptosis induction of human prostate carcinoma DU145 cells by diallyl disulfide via modulation of JNK and PI3K/AKT signaling pathways |
| Q45710561 | Apoptosis of infiltrating T cells in the central nervous system of mice infected with Theiler's murine encephalomyelitis virus. |
| Q34395580 | Apoptosis regulators and their role in tumorigenesis |
| Q35170707 | Apoptosis repressor with caspase recruitment domain modulates second mitochondrial-derived activator of caspases mimetic-induced cell death through BIRC2/MAP3K14 signalling in acute myeloid leukaemia |
| Q43509302 | Apoptosis-resistant mitochondria in T cells selected for resistance to Fas signaling |
| Q37512301 | Apoptotic Volume Decrease (AVD) Is Independent of Mitochondrial Dysfunction and Initiator Caspase Activation |
| Q33814979 | Apoptotic and effector pathways in autoimmunity |
| Q59276618 | Apoptotic responses common to cancer and inflammation |
| Q35092230 | Apoptotic signaling cascades. |
| Q42089456 | Arrestins in apoptosis |
| Q40702714 | BAX and BAK mediate p53-independent suppression of tumorigenesis |
| Q73347784 | BID-dependent and BID-independent pathways for BAX insertion into mitochondria |
| Q58289900 | BRCA1 Facilitates Stress-induced Apoptosis in Breast and Ovarian Cancer Cell Lines |
| Q33954487 | Bax, Bid and the permeabilization of the mitochondrial outer membrane in apoptosis |
| Q54042751 | Bcl-2 inhibits calcineurin-mediated Fas ligand expression in antitumor drug-treated baby hamster kidney cells. |
| Q24670606 | Bcl2L12 inhibits post-mitochondrial apoptosis signaling in glioblastoma |
| Q73177910 | Biddable death |
| Q44040283 | Blocking NF-kappaB activation in Jurkat leukemic T cells converts the survival agent and tumor promoter PMA into an apoptotic effector. |
| Q24291469 | CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-kappaB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells |
| Q51082157 | CD95(Fas/APO-1) signals ceramide generation independent of the effector stage of apoptosis. |
| Q73402316 | CD95: more than just a death factor? |
| Q46786603 | Cadmium inhibits both intrinsic and extrinsic apoptotic pathways in renal mesangial cells |
| Q40462602 | Casein kinase II (CK2) enhances death-inducing signaling complex (DISC) activity in TRAIL-induced apoptosis in human colon carcinoma cell lines. |
| Q35906438 | Caspase-8 and c-FLIPL associate in lipid rafts with NF-kappaB adaptors during T cell activation. |
| Q40478589 | Caspase-8 can be activated by interchain proteolysis without receptor-triggered dimerization during drug-induced apoptosis. |
| Q24307493 | Caspase-8 prevents sustained activation of NF-kappaB in monocytes undergoing macrophagic differentiation |
| Q53867825 | Caspase-8L expression protects CD34+ hematopoietic progenitor cells and leukemic cells from CD95-mediated apoptosis. |
| Q37446194 | Caspase-9 activation by the apoptosome is not required for fas-mediated apoptosis in type II Jurkat cells |
| Q36559701 | Caspase-containing complexes in the regulation of cell death and inflammation |
| Q24551487 | Caspase-resistant BAP31 inhibits fas-mediated apoptotic membrane fragmentation and release of cytochrome c from mitochondria |
| Q46458759 | Caspases: determination of their activities in apoptotic cells |
| Q24536096 | Caspases: pharmacological manipulation of cell death |
| Q34457741 | Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c |
| Q73540329 | Cell death in the third millennium |
| Q38544605 | Cellular FLICE-Inhibitory Protein Regulates Tissue Homeostasis. |
| Q37344754 | Ceramide and mitochondria in ischemia/reperfusion |
| Q37970353 | Ceramide and mitochondria in ischemic brain injury. |
| Q38021345 | Ceramide function in the brain: when a slight tilt is enough. |
| Q48365330 | Ceramide increases Fas-mediated apoptosis in glioblastoma cells through FLIP down-regulation |
| Q40858469 | Characterization of distinct consecutive phases in non-genotoxic p53-induced apoptosis of Ewing tumor cells and the rate-limiting role of caspase 8. |
| Q39637660 | Cisplatin and a potent platinum(IV) complex-mediated enhancement of TRAIL-induced cancer cells killing is associated with modulation of upstream events in the extrinsic apoptotic pathway. |
| Q74566420 | Cleavage of E2F-1-regulating proteins and activation of E2F-1 during CD95-induced death of thymocytes |
| Q37761322 | Combining naturally occurring polyphenols with TNF-related apoptosis-inducing ligand: a promising approach to kill resistant cancer cells? |
| Q40734726 | Contribution of death receptor and mitochondrial pathways to Fas-mediated apoptosis in the prostatic carcinoma cell line PC3. |
| Q46851241 | Conversion of CD95 (Fas) Type II into Type I signaling by sub-lethal doses of cycloheximide |
| Q39749586 | CpG oligodeoxynucleotide 5mer-induced apoptosis in MOLT-4 leukaemia cells does not require caspase 3 or new protein synthesis |
| Q34061988 | Cross-talk in cell death signaling |
| Q45001524 | Cryopreservation and thawing is associated with varying extent of activation of apoptotic machinery in subsets of ejaculated human spermatozoa |
| Q37394799 | Current concepts of mechanisms in drug-induced hepatotoxicity |
| Q28585666 | Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia |
| Q43849857 | DAP kinase activity is critical for C(2)-ceramide-induced apoptosis in PC12 cells |
| Q35641622 | Death Receptor-Induced Apoptosis Signalling Regulation by Ezrin Is Cell Type Dependent and Occurs in a DISC-Independent Manner in Colon Cancer Cells |
| Q37601161 | Death ligand concentration and the membrane proximal signaling module regulate the type 1/type 2 choice in apoptotic death signaling |
| Q30443591 | Death pathways in T cell homeostasis and their role in autoimmune diabetes |
| Q39875342 | Death receptor 5 internalization is required for lysosomal permeabilization by TRAIL in malignant liver cell lines. |
| Q28200822 | Death receptor Fas and autoimmune disease: from the original generation to therapeutic application of agonistic anti-Fas monoclonal antibody |
| Q35146582 | Death receptors and melanoma resistance to apoptosis |
| Q92564995 | Decoding the sweet regulation of apoptosis: the role of glycosylation and galectins in apoptotic signaling pathways |
| Q40135330 | Differential effects of bexarotene on intrinsic and extrinsic pathways in TRAIL-induced apoptosis in two myeloid leukemia cell lines |
| Q43902939 | Differential involvement of Bax and Bak in TRAIL-mediated apoptosis of leukemic T cells |
| Q40381787 | Differential processing of cytosolic and mitochondrial caspases |
| Q54014578 | Differential susceptibility to CD95 (Apo-1/Fas) and MHC class II-induced apoptosis during murine dendritic cell development. |
| Q44119535 | Doxorubicin-induced death in neuroblastoma does not involve death receptors in S-type cells and is caspase-independent in N-type cells |
| Q40565103 | Drug-mediated sensitization to TRAIL-induced apoptosis in caspase-8-complemented neuroblastoma cells proceeds via activation of intrinsic and extrinsic pathways and caspase-dependent cleavage of XIAP, Bcl-xL and RIP. |
| Q33723716 | Early growth response-1 is a regulator of DR5-induced apoptosis in colon cancer cells. |
| Q35827627 | Effect of lentivirus-mediated survivin transfection on the morphology and apoptosis of nucleus pulposus cells derived from degenerative human disc in vitro |
| Q35048549 | Effects of minocycline on Fas-mediated fulminant hepatitis in mice |
| Q44433323 | Elucidation of molecular events leading to neutrophil apoptosis following phagocytosis: cross-talk between caspase 8, reactive oxygen species, and MAPK/ERK activation |
| Q43853017 | Enhancement of cisplatin-induced apoptosis by infection with adeno-associated virus type 2. |
| Q44292889 | Epoxycyclohexenone inhibits Fas-mediated apoptosis by blocking activation of pro-caspase-8 in the death-inducing signaling complex. |
| Q30408769 | Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. |
| Q28569113 | Evidence for the involvement of Par-4 in ischemic neuron cell death |
| Q43796925 | Expression of the oncogenic NPM-ALK chimeric protein in human lymphoid T-cells inhibits drug-induced, but not Fas-induced apoptosis. |
| Q28248826 | Fas ligation on macrophages enhances IL-1R1-Toll-like receptor 4 signaling and promotes chronic inflammation |
| Q40735901 | Fas, ceramide and serum withdrawal induce apoptosis via a common pathway in a type II Jurkat cell line. |
| Q24300122 | Fas-associated factor 1, FAF1, is a member of Fas death-inducing signaling complex |
| Q31120918 | Fas-associated protein with death domain (FADD)-independent recruitment of c-FLIPL to death receptor 5. |
| Q46592230 | Fas-independent mitochondrial damage triggers cardiomyocyte death after ischemia-reperfusion |
| Q40637428 | Fas-stimulated generation of reactive oxygen species or exogenous oxidative stress sensitize cells to Fas-mediated apoptosis |
| Q39758145 | Fas/CD95-mediated apoptosis of type II cells is blocked by Toxoplasma gondii primarily via interference with the mitochondrial amplification loop |
| Q51052600 | Ferritin--a mediator of apoptosis? |
| Q40645804 | Flavonoid quercetin sensitizes a CD95-resistant cell line to apoptosis by activating protein kinase Calpha |
| Q43991092 | Gastric irritant-induced apoptosis in guinea pig gastric mucosal cells in primary culture |
| Q43747874 | Geranylgeraniol, an intermediate product in mevalonate pathway, induces apoptotic cell death in human hepatoma cells: death receptor-independent activation of caspase-8 with down-regulation of Bcl-xL expression |
| Q40765067 | Glutathione dependence of caspase-8 activation at the death-inducing signaling complex |
| Q43228472 | Glycolysis inhibition sensitizes tumor cells to death receptors-induced apoptosis by AMP kinase activation leading to Mcl-1 block in translation. |
| Q43614304 | Granulocyte colony-stimulating factor inhibits Fas-triggered apoptosis in bone marrow cells isolated from patients with refractory anemia with ringed sideroblasts |
| Q40837904 | Granzyme B induces BID-mediated cytochrome c release and mitochondrial permeability transition |
| Q28211642 | HIV-1 protease processes procaspase 8 to cause mitochondrial release of cytochrome c, caspase cleavage and nuclear fragmentation |
| Q34147508 | Hepatocyte Death: A Clear and Present Danger |
| Q48003529 | Hepatocyte growth factor induces Mcl-1 in primary human hepatocytes and inhibits CD95-mediated apoptosis via Akt. |
| Q35371553 | High cell surface death receptor expression determines type I versus type II signaling |
| Q40831146 | High proportion of CD95(+) and CD38(+) in cultured CD8(+) T cells predicts acute rejection and infection, respectively, in kidney recipients |
| Q24650648 | Host cell manipulation by the human pathogen Toxoplasma gondii |
| Q36515075 | How T lymphocytes switch between life and death |
| Q31037798 | Hyperforin inhibits Akt1 kinase activity and promotes caspase-mediated apoptosis involving Bad and Noxa activation in human myeloid tumor cells |
| Q37011260 | Hypoxia-mediated down-regulation of Bid and Bax in tumors occurs via hypoxia-inducible factor 1-dependent and -independent mechanisms and contributes to drug resistance |
| Q36754320 | IL-1β promotes antimicrobial immunity in macrophages by regulating TNFR signaling and caspase-3 activation |
| Q36207483 | Identifying Novel Candidate Genes Related to Apoptosis from a Protein-Protein Interaction Network |
| Q44791845 | Impairment of death-inducing signalling complex formation in CD95-resistant human primary lymphoma B cells |
| Q40724622 | In vivo and in vitro activation of caspase-8 and -3 associated with Helicobacter pylori infection |
| Q28208747 | Inactivation of caspase-8 on mitochondria of Bcl-xL-expressing MCF7-Fas cells: role for the bifunctional apoptosis regulator protein |
| Q58560592 | Increased Ripk1-mediated bone marrow necroptosis leads to myelodysplasia and bone marrow failure in mice |
| Q45059559 | Increased sensitivity of early apoptotic cells to complement-mediated lysis |
| Q40438367 | Indomethacin-induced activation of the death receptor-mediated apoptosis pathway circumvents acquired doxorubicin resistance in SCLC cells |
| Q34146806 | Inducible resistance to Fas-mediated apoptosis in B cells |
| Q35596669 | Induction of apoptosis through the activation of SAPK/JNK followed by the expression of death receptor Fas in X-irradiated cells. |
| Q52550334 | Induction of hepatocyte proliferation and death by modulation of T-Antigen expression |
| Q40674172 | Inhibition of glucose metabolism sensitizes tumor cells to death receptor-triggered apoptosis through enhancement of death-inducing signaling complex formation and apical procaspase-8 processing |
| Q44381508 | Inhibition of phosphatidylinositol 3-kinase sensitizes vascular endothelial cells to cytokine-initiated cathepsin-dependent apoptosis |
| Q52551409 | Inorganic mercury attenuates CD95-mediated apoptosis by interfering with formation of the death inducing signaling complex. |
| Q62391840 | Interferon-γ Sensitizes Human Myeloid Leukemia Cells to Death Receptor-mediated Apoptosis by a Pleiotropic Mechanism |
| Q44567499 | Involvement of mitochondria in acetaminophen-induced apoptosis and hepatic injury: roles of cytochrome c, Bax, Bid, and caspases |
| Q43722376 | Involvement of protein kinase C-delta in DNA damage-induced apoptosis |
| Q37290808 | Killing of p53-deficient hepatoma cells by parvovirus H-1 and chemotherapeutics requires promyelocytic leukemia protein |
| Q53380339 | Lack of Fas (APO-1/CD95) gene structural alterations or transcript variant ratio changes in breast cancer |
| Q36961820 | Latent membrane protein 2A inhibits transforming growth factor-beta 1-induced apoptosis through the phosphatidylinositol 3-kinase/Akt pathway |
| Q37233180 | Life and death by death receptors |
| Q36858872 | Life and death in peripheral T cells |
| Q28594574 | Lifeguard Inhibits Fas Ligand-mediated Endoplasmic Reticulum-Calcium Release Mandatory for Apoptosis in Type II Apoptotic Cells |
| Q24319929 | Lifeguard/neuronal membrane protein 35 regulates Fas ligand-mediated apoptosis in neurons via microdomain recruitment |
| Q35538226 | Live and let die: regulatory mechanisms in Fas-mediated apoptosis. |
| Q40245914 | Loss of caspase-9 provides genetic evidence for the type I/II concept of CD95-mediated apoptosis |
| Q35682077 | Lyapunov exponents and phase diagrams reveal multi-factorial control over TRAIL-induced apoptosis |
| Q90044168 | M51R and Delta-M51 matrix protein of the vesicular stomatitis virus induce apoptosis in colorectal cancer cells |
| Q40430386 | MAPK/ERK signaling in activated T cells inhibits CD95/Fas-mediated apoptosis downstream of DISC assembly |
| Q28344462 | Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis |
| Q33954055 | Mechanisms of neurotoxic injury and cell death. |
| Q73839432 | Mice lacking TNFalpha receptors 1 and 2 are resistant to death and fulminant liver injury induced by agonistic anti-Fas antibody |
| Q34083604 | Mitochondrial intermembrane junctional complexes and their role in cell death |
| Q39676008 | Molecular ordering of the initial signaling events of CD95. |
| Q34177539 | Molecular signals in anti-apoptotic survival pathways. |
| Q35603396 | Monoclonal antibody therapeutics and apoptosis |
| Q37679250 | Monte carlo study elucidates the type 1/type 2 choice in apoptotic death signaling in healthy and cancer cells |
| Q39447479 | Morphology of mitochondrial permeability transition: morphometric volumetry in apoptotic cells |
| Q52114306 | Motoneuron death triggered by a specific pathway downstream of Fas. potentiation by ALS-linked SOD1 mutations. |
| Q38602933 | Multiple and synergistic deregulations of apoptosis-controlling genes in pancreatic carcinoma cells |
| Q40688810 | Murine coronavirus-induced apoptosis in 17Cl-1 cells involves a mitochondria-mediated pathway and its downstream caspase-8 activation and bid cleavage |
| Q33968823 | Myc potentiates apoptosis by stimulating Bax activity at the mitochondria |
| Q39986568 | NLRP3 regulates a non-canonical platform for caspase-8 activation during epithelial cell apoptosis. |
| Q43002833 | Nitric oxide donors inhibit formation of the Apaf-1/caspase-9 apoptosome and activation of caspases |
| Q37330810 | Nitric oxide-mediated apoptosis of neutrophils through caspase-8 and caspase-3-dependent mechanism |
| Q40627137 | Novel non-peptide inhibitors targeting death receptor-Mediated apoptosis |
| Q39542691 | Oligodeoxynucleotide 5mers containing a 5'-CpG induce apoptosis through a mitochondrial mechanism in T lymphocytic leukaemia cells |
| Q40432807 | On the mechanism of alkylphosphocholine (APC)-induced apoptosis in tumour cells |
| Q35077031 | Oncolytic vesicular stomatitis virus induces apoptosis in U87 glioblastoma cells by a type II death receptor mechanism and induces cell death and tumor clearance in vivo |
| Q40001770 | P53-mediated upregulation of DcR1 impairs oxaliplatin/TRAIL-induced synergistic anti-tumour potential in colon cancer cells |
| Q61813133 | PKCμ prevents CD95-mediated apoptosis and enhances proliferation in pancreatic tumour cells |
| Q28591409 | Palmitoylation is required for efficient Fas cell death signaling |
| Q40639880 | Perillyl alcohol as a radio-/chemosensitizer in malignant glioma |
| Q40765687 | Phorbol 12-myristate 13-acetate inhibits death receptor-mediated apoptosis in Jurkat cells by disrupting recruitment of Fas-associated polypeptide with death domain |
| Q40777275 | Phosphorylation of bid by casein kinases I and II regulates its cleavage by caspase 8. |
| Q39984111 | Phosphorylation of murine caspase-9 by the protein kinase casein kinase 2 regulates its cleavage by caspase-8. |
| Q33183062 | Piceatannol, a hydroxylated analog of the chemopreventive agent resveratrol, is a potent inducer of apoptosis in the lymphoma cell line BJAB and in primary, leukemic lymphoblasts |
| Q34054886 | Positive and negative regulation of apoptotic pathways by cytotoxic agents in hematological malignancies. |
| Q46254854 | Possible role of apoptosis in the pathogenesis and clinical evolution of radicular cyst: an immunohistochemical study |
| Q40669025 | Post-translational modification of Bid has differential effects on its susceptibility to cleavage by caspase 8 or caspase 3. |
| Q43891833 | Potentiation of Fas-mediated apoptosis by an engineered glycosylphosphatidylinositol-linked Fas. |
| Q44807301 | Preconditioning with cardioplegia is more effective in reducing apoptosis than is preconditioning with ischemia in the human myocardium |
| Q35600583 | Presence and significance of somatic cell apoptosis markers in human ejaculated spermatozoa |
| Q36612379 | Pro- and anti-apoptotic activities of protozoan parasites |
| Q35963747 | Proapoptotic BID is required for myeloid homeostasis and tumor suppression |
| Q42642723 | Processing of metacaspase into a cytoplasmic catalytic domain mediating cell death in Leishmania major |
| Q52147898 | Programmed Cell Death in the Honey Bee (Apis mellifera) (Hymenoptera: Apidae) Worker Brain Induced by Imidacloprid. |
| Q37466253 | Programmed cell death pathways and current antitumor targets |
| Q73756747 | Properties of DNA fragmentation activity generated by ATP depletion |
| Q91955777 | Prospective clinical biomarkers of caspase-mediated apoptosis associated with neuronal and neurovascular damage following stroke and other severe brain injuries: Implications for chronic neurodegeneration |
| Q44607423 | Protection of human pancreatic islets using a lentiviral vector expressing two genes: cFLIP and GFP. |
| Q36368472 | Protein kinase B regulates T lymphocyte survival, nuclear factor kappaB activation, and Bcl-X(L) levels in vivo |
| Q43800227 | Protein kinase C inhibits singlet oxygen-induced apoptosis by decreasing caspase-8 activation |
| Q28189776 | Protein kinase C regulates FADD recruitment and death-inducing signaling complex formation in Fas/CD95-induced apoptosis |
| Q33927958 | Reactive oxygen species and vascular cell apoptosis in response to angiotensin II and pro-atherosclerotic factors |
| Q52369544 | Regulation of TNF-Related Apoptosis-Inducing Ligand Signaling by Glycosylation. |
| Q34117899 | Regulation of death receptor-mediated apoptosis pathways |
| Q24673747 | Regulation of lymphocyte apoptosis by interferon regulatory factor 4 (IRF-4) |
| Q29037634 | Regulation of the cell cycle and apoptosis by the oncogenes of adenovirus |
| Q57204436 | Reovirus-induced apoptosis requires both death receptor- and mitochondrial-mediated caspase-dependent pathways of cell death |
| Q34355580 | Reovirus-induced apoptosis requires mitochondrial release of Smac/DIABLO and involves reduction of cellular inhibitor of apoptosis protein levels. |
| Q42529045 | Requirement of Apaf-1 for mitochondrial events and the cleavage or activation of all procaspases during genotoxic stress-induced apoptosis |
| Q36101164 | Resistance to TRAIL is mediated by DARPP-32 in gastric cancer |
| Q39277444 | Restimulation-induced cell death: new medical and research perspectives. |
| Q46181262 | Retinoic acid regulates Fas-induced apoptosis in Jurkat T cells: reversal of mitogen-mediated repression of Fas DISC assembly. |
| Q40487706 | Retrovirally transferred genes inhibit apoptosis in an insulin-secreting cell line: implications for islet transplantation |
| Q39180895 | Role of altholactone in inducing type II apoptosis signalling pathway and expression of cancer-related genes in cervical carcinoma HeLa cell line |
| Q37592358 | Role of apoptosis-inducing factor (Aif) in the T cell lineage |
| Q40654484 | Role of ceramide in mediating apoptosis of irradiated LNCaP prostate cancer cells |
| Q36489056 | Role of insulin receptor and balance in insulin receptor isoforms A and B in regulation of apoptosis in simian virus 40-immortalized neonatal hepatocytes |
| Q34977059 | Role of the Fas/Fas ligand system in female reproductive organs: survival and apoptosis |
| Q43098985 | Role of the cytoskeleton in Cd2+-induced death of mouse mesangial cells |
| Q34449938 | Roles of c-FLIP in Apoptosis, Necroptosis, and Autophagy |
| Q40602856 | S-Nitrosation regulates the activation of endogenous procaspase-9 in HT-29 human colon carcinoma cells |
| Q34310555 | Shared pathways: death receptors and cytotoxic drugs in cancer therapy |
| Q34563012 | Signaling to gene activation and cell death by tumor necrosis factor receptors and Fas. |
| Q43237439 | Small interfering RNA-mediated silencing of heat shock protein 27 (HSP27) Increases chemosensitivity to paclitaxel by increasing production of reactive oxygen species in human ovarian cancer cells (HO8910). |
| Q28592917 | Sphingosine-1-phosphate phosphohydrolase in regulation of sphingolipid metabolism and apoptosis |
| Q43583285 | Staurosporine and conventional anticancer drugs induce overlapping, yet distinct pathways of apoptosis and caspase activation |
| Q74355558 | Stimulation of the mitogen-activated protein kinase pathway antagonizes TRAIL-induced apoptosis downstream of BID cleavage in human breast cancer MCF-7 cells |
| Q34184469 | Sub-lethal irradiation of human colorectal tumor cells imparts enhanced and sustained susceptibility to multiple death receptor signaling pathways |
| Q40629513 | Suppression of extracellular signal-related kinase and activation of p38 MAPK are two critical events leading to caspase-8- and mitochondria-mediated cell death in phytosphingosine-treated human cancer cells |
| Q40774861 | Sustained hyposmotic stress induces cell death: apoptosis by defeat |
| Q39400792 | Switching from aerobic glycolysis to oxidative phosphorylation modulates the sensitivity of mantle cell lymphoma cells to TRAIL. |
| Q40288848 | TNF-receptor I defective in internalization allows for cell death through activation of neutral sphingomyelinase |
| Q44441750 | TNF-α-induced cell death in ethanol-exposed cells depends on p38 MAPK signaling but is independent of Bid and caspase-8 |
| Q74083351 | TRAIL-induced apoptosis of thyroid cancer cells: potential for therapeutic intervention |
| Q39197722 | TRAIL-induced expression of uPA and IL-8 strongly enhanced by overexpression of TRAF2 and Bcl-xL in pancreatic ductal adenocarcinoma cells |
| Q36011879 | Targeted therapy in Ewing sarcoma |
| Q34791120 | Targeting death and decoy receptors of the tumour-necrosis factor superfamily |
| Q37882480 | Targeting the extrinsic apoptosis signaling pathway for cancer therapy |
| Q36174027 | The Apaf-1-binding protein Aven is cleaved by Cathepsin D to unleash its anti-apoptotic potential |
| Q40628674 | The CB1/VR1 agonist arvanil induces apoptosis through an FADD/caspase-8-dependent pathway |
| Q35561587 | The CD95 type I/type II model |
| Q35091401 | The CD95(APO-1/Fas) DISC and beyond |
| Q40503168 | The apoptotic pathway triggered by the Fhit protein in lung cancer cell lines is not affected by Bcl-2 or Bcl-x(L) overexpression |
| Q40387564 | The death receptor pathway is not involved in alloreactive T-cell induced mitochondrial membrane permeability. |
| Q37982722 | The emerging role of matrix metalloproteases of the ADAM family in male germ cell apoptosis |
| Q51039137 | The expression of apoptosis-regulatory proteins in B lymphocytes from patients with multiple sclerosis. |
| Q40862170 | The glucagon-like peptide-2 receptor mediates direct inhibition of cellular apoptosis via a cAMP-dependent protein kinase-independent pathway |
| Q33292139 | The human papillomavirus 16 E6 protein binds to Fas-associated death domain and protects cells from Fas-triggered apoptosis. |
| Q40740004 | The human papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cells from TNF-induced apoptosis. |
| Q35098707 | The human papillomavirus 16 E6 protein can either protect or further sensitize cells to TNF: effect of dose |
| Q46950108 | The mitogen-activated protein kinase pathway can inhibit TRAIL-induced apoptosis by prohibiting association of truncated Bid with mitochondria |
| Q33650479 | The prosurvival activity of ascites against TRAIL is associated with a shorter disease-free interval in patients with ovarian cancer |
| Q44539646 | The proteasome inhibitor PS-341 overcomes TRAIL resistance in Bax and caspase 9-negative or Bcl-xL overexpressing cells |
| Q37861557 | The secreted protease factor CPAF is responsible for degrading pro-apoptotic BH3-only proteins in Chlamydia trachomatis-infected cells |
| Q41871248 | Thymineless death in F10-treated AML cells occurs via lipid raft depletion and Fas/FasL co-localization in the plasma membrane with activation of the extrinsic apoptotic pathway |
| Q40171442 | Toxoplasma gondii inhibits Fas/CD95-triggered cell death by inducing aberrant processing and degradation of caspase 8. |
| Q41264614 | Toxoplasma gondii inhibits cytochrome c-induced caspase activation in its host cell by interference with holo-apoptosome assembly |
| Q39705488 | Translocation of Fas by LPA prevents ovarian cancer cells from anti-Fas-induced apoptosis |
| Q43903493 | Tumor-cell resistance to death receptor--induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax. |
| Q36161031 | Two CD95 tumor classes with different sensitivities to antitumor drugs |
| Q44403194 | Two-step formation of 1H NMR visible mobile lipids during apoptosis of paclitaxel-treated K562 cells. |
| Q33208795 | Type I and type II reactions in TRAIL-induced apoptosis -- results from dose-response studies. |
| Q28203236 | Uncleaved BAP31 in association with A4 protein at the endoplasmic reticulum is an inhibitor of Fas-initiated release of cytochrome c from mitochondria |
| Q42268479 | Up-regulation of FLIP in cisplatin-selected HeLa cells causes cross-resistance to CD95/Fas death signalling |
| Q43864431 | Upregulation of Bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines |
| Q43972734 | Upregulation of the Fas receptor death-inducing signaling complex after traumatic brain injury in mice and humans. |
| Q34234104 | Viral proteins and the mitochondrial apoptotic checkpoint |
| Q34308884 | Viruses and apoptosis |
| Q33828332 | Vpr-host interactions during HIV-1 viral life cycle |
| Q40508778 | Water induces autocrine stimulation of tumor cell killing through ATP release and P2 receptor binding |
| Q38531621 | c-Myc and caspase-2 are involved in activating Bax during cytotoxic drug-induced apoptosis |
| Q35752871 | c-Myc primed mitochondria determine cellular sensitivity to TRAIL-induced apoptosis |
| Q36983175 | microRNAs and death receptors. |
| Q33948252 | p38-mediated regulation of an Fas-associated death domain protein-independent pathway leading to caspase-8 activation during TGFbeta-induced apoptosis in human Burkitt lymphoma B cells BL41. |
| Q34648862 | vMIA, a viral inhibitor of apoptosis targeting mitochondria |
Search more.